Biomimedica

Biomimedica

Biomimedica is pioneering new approaches to joint repair through a proprietary synthetic cartilage technology.

Related Articles & Links

July 7, 2014 Biomimedica Secures $249,999 New Round

July 16, 2013 Synthetic cartilage implant designed to restore natural joint mechanics in osteoarthritis patients

June 21, 2012 Biomimedica® Announces the Closing of its Oversubscribed Series B Financing

June 20, 2012 Synthetic cartilage developer Biomimedica nears $14.2M VC goal

Our Philosophy

We focus on portfolio returns, big opportunities, high-quality team, and financials that demonstrate a deep understanding of the business. We look for companies where our experience and expertise can add value to produce better outcomes for both entrepreneurs and our investments.

Our Networks

Relationships and people matter. Over the decades, we have developed personal relationships with other quality investors (both Angels and VCs), service providers, and domain experts. If we do not know the answer, we know someone who does.

Our Mentorship

When the company wins, we all win. To maximize success, we often serve as advisors or board members. Both art and science are involved in building a supportive and useful board as well as maintaining solid investor relations. Good financial discipline lays the foundation for success and informs company strategy.

Our Strategy

We like healthcare, especially digital health, but also diagnostics, devices, and bio/genomics. For funding, we often co-invest with other investors and are happy to lead investment rounds. We know term sheets and what drives syndicated investment rounds.
Scroll to top